158 related articles for article (PubMed ID: 28122352)
1. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma.
Li J; Hansen BE; Peppelenbosch MP; De Man RA; Pan Q; Sprengers D
Oncotarget; 2017 Feb; 8(9):15193-15204. PubMed ID: 28122352
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
3. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
4. The racial disparity of nasopharyngeal carcinoma based on the database analysis.
Zhou L; Shen N; Li G; Ding J; Liu D; Huang X
Am J Otolaryngol; 2019; 40(6):102288. PubMed ID: 31526630
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
7. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
8. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.
Yang D; Hanna DL; Usher J; LoCoco J; Chaudhari P; Lenz HJ; Setiawan VW; El-Khoueiry A
Cancer; 2014 Dec; 120(23):3707-16. PubMed ID: 25081299
[TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
10. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
13. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
[TBL] [Abstract][Full Text] [Related]
14. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.
Wong RJ; Corley DA
Dig Dis Sci; 2009 Sep; 54(9):2031-9. PubMed ID: 19117131
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma.
Aparo S; Goel S; Lin D; Ohri N; Schwartz JM; Lo Y; Kaubisch A
Cancer; 2014 Dec; 120(23):3683-90. PubMed ID: 25081065
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
[TBL] [Abstract][Full Text] [Related]
18. Association of nativity with survival among adults with hepatocellular carcinoma.
Zhou K; Song Z; Rostomian N; Dodge JL; Stern MC; Setiawan VW; Terrault NA; Cockburn MG; Liu L
J Natl Cancer Inst; 2023 Jul; 115(7):861-869. PubMed ID: 37160726
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
20. Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer.
Wang F; Zheng W; Bailey CE; Mayer IA; Pietenpol JA; Shu XO
Cancer Res; 2021 Feb; 81(4):1163-1170. PubMed ID: 33272926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]